©2020 AEA3 WEB
Image default
News

Oxford Covid vaccine could build immunity in older people – study

Phase 2 trial data shows strong immune response and better tolerance in over-70s

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The University of Oxford is expected to release data on the efficacy of its coronavirus vaccine candidate in the coming weeks, with the latest trial results suggesting it produces a strong immune response in older adults.

The ChAdOx1 nCov-2019 vaccine has been shown to trigger a robust immune response in healthy adults aged 56-69 and over 70.

Continue reading…

Related posts

Covid: care home called police after woman sneaked in to see husband

AEA3

Dear Evan Hansen wins three awards as virtual Oliviers honour theatre

AEA3

Banks lent £1.9tn linked to ecosystem and wildlife destruction in 2019 – report

AEA3

Your ads here. Click here